Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3325-3327

  Kim, Young S ^a   Liu, Quingxiang ^a   Chow, Lucien L ^a   Chambers, Henry F ^a,b   Täuber, Martin G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Infectious Diseases Laboratory/SFGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULBACTAM; TROVAFLOXACIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; ENDOCARDITIS; INTRAMUSCULAR DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STRAIN DIFFERENCE;

EID: 0031757036     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3325     Document Type: Article

References (31)

1. Bisno, A., W. Dismukes, D. Durak, E. Kaplan, A. Karchmer, D. Kaye, S. Rahimtoola, M. Sande, J. Sanford, C. Watanakunakorn, and W. Wilson. 1989. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA 261:1471-4177.
2. Blumberg, H. M., D. Rimland, D. J. Carroll, P. Terry, and I. K. Wachsmuth. 1991. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J. Infect. Dis. 163:1279-1285.
3. Bonilla, H. F., L. T. Zarins, S. F. Bradley, and C. A. Kauffman. 1996. Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin. Diagn. Microbiol. Infect. Dis. 26:17-21.
4. Brumfitt, W., J. Hamilton-Miller, and S. Shah. 1989. Methicillin-resistant Staphylococcus aureus. N. Engl. J. Med. 320:1188-1196.
5. Cantoni, A., L. Wenger, M. P. Glauser, and J. Bille. 1989. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 159:989-993.
6. Chambers, H., M. Kartalija, and M. Sande. 1995. Ampicillin, sulbactam and rifampin combination treatments of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J. Infect. Dis. 171:897-902.
7. Chambers, H. F., and S. Kennedy. 1990. Effect of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. J. Infect. Dis. 34:510-514.
8. Crane, L., D. P. Levine, M. J. Zervos, and G. Cummings. 1986. Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev. Infect. Dis. 8:364-373.
9. Entenza, J. M., J. Voullamoz, M. P. Glauser, and P. Moreillon. 1997. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 41:1662-1667.
10. Franciolli, M., J. Bille, M. P. Glauser, and P. Moreillon. 1991. β-Lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 163:514-523.
11. Gillespie, M. T., J. W. May, and R. Skurray. 1985. Antibiotic resistance in Staphylococcus aureus isolated at an Australian hospital between 1946 and 1981. J. Med. Microbiol. 19:137-147.
12. Girard, A. E., D. Girard, T. D. Gootz, J. A. Faiella, and C. R. Cimochowski. 1995. In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis. Antimicrob. Agents Chemother. 39:2210-2216.
13. Hartman, B., and A. Tomasz. 1986. Expression of methicillin resistance in heterogenous strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 29:85-92.
14. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
15. Hook, E., R. Roberts, and M. A. Sande. 1975. Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob. Agents Chemother. 8:564-570.
16. Jevons, M. P. 1961. "Celbenin"-resistant staphylococci. Br. Med. J. 1:124-125.
17. Kaatz, G. W., S. L. Barriere, D. R. Schaberg, and R. Fekety. 1987. The emergence of resistance to ciprofloxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 20:753-758.
18. Kaatz, G. W., S. M. Seo, J. R. Aeschlimann, H. H. Houlihan, R.-C. Mercier, and M. J. Rybak. 1998. Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 42:254-256.
19. Kim, Y. S., Q. Liu, L. L. Chow, and M. G. Tauber. 1997. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:1186-1189.
20. Levine, D., B. Fromm, and B. Reddy. 1991. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674-680.
21. Martin, R., and K. R. Wilkox. 1997. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States. JAMA 278:1145-1146.
22. Noble, W. C., Z. Virani, and R. G. A. Cree. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195-198.
23. Peacock, J., F. Marsik, and R. Wenzel. 1980. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann. Intern. Med. 93:526-532.
24. Perlman, B., and L. Freedman. 1971. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J. Biol. Med. 44:206-213.
25. Piddock, L. J. 1994. New quinolones and gram-positive bacteria. Antimicrob. Agents Chemother. 38:163-169.
26. Sanabria, T., J. Alpert, and R. Goldberg. 1990. Increasing frequency of staphylococcal infective endocarditis. Experience at a university hospital, 1981 through 1988. Arch. Intern. Med. 150:1305-1309.
27. Sanders, W. E. 1988. Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections. Rev. Infect. Dis. 10:528-543.
28. Scheel, O., D. J. Lyon, V. T. Rosdahl, F. A. B. Ademyemi-Doro, T. K. W. Ling, and A. F. B. Cheng. 1996. In vitro susceptibility of isolates of methicillin-resistant Staphylococcus aureus 1988-1993. J. Antimicrob. Chemother. 37: 243-251.
29. Small, P., and H. F. Chambers. 1990. Staphylococcus aureus endocarditis in injection drug users. Antimicrob. Agents Chemother. 34:1227-1231.
30. Teng, R., T. E. Liston, and S. C. Harris. 1996. Multiple dose pharmacokinetics and safety of trovafloxacin in healthy volunteers. J. Antimicrob. Chemother. 37:955-963.
31. Watanakunakorn, C., and T. Burkert. 1993. Infective endocarditis at a large community teaching hospital. Medicine 72:90-102.